For decades, none had achieved noteworthy success in developing and supplying high-quality laboratory-use enzymes in Korea despite ever-increasing demand every year, and it motivated us to challenge this formidable task, leading to the establishment of Enzynomics in 2007. Since then, every drop of sweat has been put into this initiative to produce enzymes for research and diagnostics, resulting in the production of high-quality recombinant enzymes that range from restriction enzymes to DNA polymerases, virtually covering all enzymes needed for modern life science.
“ We produce approximately 200 highest purity enzymes, consisting of 130 restriction endonucleases, 20 DNA polymerases, and 50 modifying enzymes. ”
We are happy to supply them affordably than ever to the scientists and researchers, domestic and abroad, in the field of life science. We produce approximately 200 highest purity enzymes, consisting of 130 restriction endonucleases, 20 DNA polymerases, and 50 modifying enzymes. All the enzymes went through rigorous quality control using many different assays developed in our company. We also provide various high-quality experiment kits using our own enzymes as the key ingredients. One example is the site-directed mutagenesis kit that allows researchers to introduce many different types of mutations easily than ever. The other example is cloning kits which are very convenient and easy to use and guarantee almost foolproof success in cloning PCR-amplified DNA fragments into target vectors for many experimental purposes.
“Our next aim is to develop cytokines and other proteins that have biological modifying functions.”
With these successful experiences, Enzynomics has secured a position as a major enzyme supplier in the domestic market, and now in a position to export those enzymes and kits to many different countries. In the near future, we envision Enzynomics as a global brand, competing with pioneering brands of the world's leading enzyme companies. Our next aim is to develop cytokines and other proteins that have biological modifying functions. The successful accomplishment in this stage will lead us to move into the development of innovative protein drugs and therapeutic enzymes in the hopes of making a significant contribution to the health and welfare of human beings.
281-9, Munji-ro, Yuseong-gu, Daejeon, 34050, Republic of Korea
copyright© Enzynomics co Ltd, All rights reserved.